NCT04911543View on ClinicalTrials.gov

A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]-JNJ-70099731 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

13

Participants

Timeline

Start Date

June 23, 2021

Primary Completion Date

February 1, 2022

Study Completion Date

February 1, 2022

Conditions

Healthy

Interventions

DRUG

[18F]-JNJ-70099731

\[18F\]JNJ-70099731 injection will be administered intravenously.

Trial Locations (1)

3000

UZ Leuven Gasthuisberg, Leuven

All Listed Sponsors

lead

Janssen Research & Development, LLC

INDUSTRY